1. Home
  2. SCHL vs TRML Comparison

SCHL vs TRML Comparison

Compare SCHL & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCHL
  • TRML
  • Stock Information
  • Founded
  • SCHL 1920
  • TRML 2021
  • Country
  • SCHL United States
  • TRML United States
  • Employees
  • SCHL N/A
  • TRML N/A
  • Industry
  • SCHL Books
  • TRML Biotechnology: Pharmaceutical Preparations
  • Sector
  • SCHL Consumer Discretionary
  • TRML Health Care
  • Exchange
  • SCHL Nasdaq
  • TRML Nasdaq
  • Market Cap
  • SCHL 644.1M
  • TRML 598.9M
  • IPO Year
  • SCHL 1987
  • TRML N/A
  • Fundamental
  • Price
  • SCHL $27.69
  • TRML $47.70
  • Analyst Decision
  • SCHL Strong Buy
  • TRML Hold
  • Analyst Count
  • SCHL 1
  • TRML 12
  • Target Price
  • SCHL $37.00
  • TRML $47.04
  • AVG Volume (30 Days)
  • SCHL 244.5K
  • TRML 1.7M
  • Earning Date
  • SCHL 09-18-2025
  • TRML 11-06-2025
  • Dividend Yield
  • SCHL 2.95%
  • TRML N/A
  • EPS Growth
  • SCHL N/A
  • TRML N/A
  • EPS
  • SCHL N/A
  • TRML N/A
  • Revenue
  • SCHL $1,625,500,000.00
  • TRML N/A
  • Revenue This Year
  • SCHL $4.15
  • TRML N/A
  • Revenue Next Year
  • SCHL $3.96
  • TRML N/A
  • P/E Ratio
  • SCHL N/A
  • TRML N/A
  • Revenue Growth
  • SCHL 2.25
  • TRML N/A
  • 52 Week Low
  • SCHL $15.77
  • TRML $11.56
  • 52 Week High
  • SCHL $34.18
  • TRML $47.75
  • Technical
  • Relative Strength Index (RSI)
  • SCHL 64.80
  • TRML 94.34
  • Support Level
  • SCHL $26.69
  • TRML $22.31
  • Resistance Level
  • SCHL $28.20
  • TRML $47.69
  • Average True Range (ATR)
  • SCHL 0.99
  • TRML 0.92
  • MACD
  • SCHL 0.08
  • TRML 1.57
  • Stochastic Oscillator
  • SCHL 89.01
  • TRML 99.73

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

Share on Social Networks: